United Therapeutics (UTHR) Free Cash Flow (2009 - 2026)
United Therapeutics' Free Cash Flow was $205.6 million in Q2 2026, up 58.8% from $129.5 million a year earlier but down 43.3% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Free Cash Flow (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, United Therapeutics' Free Cash Flow was $1.09 billion through Jun 30, 2026, up 2.1% year-over-year; for FY2025, it was $1.04 billion, down 3.7% from FY2024.
- Free Cash Flow shows a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
- In earlier years, Free Cash Flow was $1.08 billion in FY2024 (+44.5%), $747.6 million in FY2023 (+12.6%), $663.7 million in FY2022 (+39.0%) and $477.4 million in FY2021 (-31.4%).
- Quarterly Free Cash Flow has moved between $61.6 million (Q2 2023) and $386.3 million (Q1 2025) over five years.
- Compared with a year earlier, Free Cash Flow was higher in five of the last eight quarters, with growth averaging 35.2%.
- The best year-over-year quarter for Free Cash Flow over five years was Q4 2024 (growth of 253.5%); the worst was Q2 2023 (a decline of 44.0%).
- Per Business Quant data, UTHR's Free Cash Flow in the three quarters before Q2 2026 was $362.5 million (Q1 2026), $173.3 million (Q4 2025) and $351.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.34 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 302.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.01 Bn |
| 10 | United Therapeutics | 23.13 Bn | 12.62 Bn | 683.80 Mn | 205.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 205.60 Mn |
| Mar 31, 2026 | 362.50 Mn |
| Dec 31, 2025 | 173.30 Mn |
| Sep 30, 2025 | 351.60 Mn |
| Jun 30, 2025 | 129.50 Mn |
| Mar 31, 2025 | 386.30 Mn |
| Dec 31, 2024 | 254.50 Mn |
| Sep 30, 2024 | 300.70 Mn |
| Jun 30, 2024 | 187.10 Mn |
| Mar 31, 2024 | 338.30 Mn |
| Dec 31, 2023 | 72.00 Mn |
| Sep 30, 2023 | 280.50 Mn |
| Jun 30, 2023 | 61.60 Mn |
| Mar 31, 2023 | 333.50 Mn |
| Dec 31, 2022 | 88.70 Mn |
| Sep 30, 2022 | 189.80 Mn |
| Jun 30, 2022 | 110.00 Mn |
| Mar 31, 2022 | 275.20 Mn |
| Dec 31, 2021 | 104.00 Mn |
| Sep 30, 2021 | 162.30 Mn |
API Access
United Therapeutics Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();